Compare StocksABBV vs CMS

AbbVie Inc. (ABBV) vs CMS Energy Corporation (CMS): Which Is the Better Buy in 2026?

As of 2026-08-03, ABBV is overvalued at $251, with a DCF intrinsic value of $178 and a margin of safety of -41%. CMS is overvalued at $72, with an intrinsic value of $11 and a margin of safety of -547%. Of the two, ABBV has the wider margin of safety.

ABBV
AbbVie Inc.
$250.94
VS
CMS
CMS Energy Corporation
$71.99

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
CMS
  • Each dollar of retained earnings has created $2.38 of earning power — management is an exceptional capital allocator.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
CMS
  • CMS Energy Corporation scores only 25/100 on the Economic Moat Score, suggesting limited durable competitive advantages.
  • PEG ratio of 2.78 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • High leverage (1.83x net debt/equity) combined with thin interest coverage (-1.0x) poses financial risk.

Key Valuation Metrics

Learn more →
ABBV
CMS
Valuation
N/A
Free Cash Flow
$-2.20B
N/A
FCF Yield
-9.74%
70.89
Trailing P/E
21.62
15.41
Forward P/E
17.31
Quality & Moat
27.60%
ROIC
4.02%
N/A
ROE
9.16%
72.79%
Gross Margin
40.31%
0.41
PEG Ratio
2.78
Balance Sheet Safety
N/A
Net Debt / Equity
1.83
N/A
Interest Coverage
N/A
2.06
Net Debt / EBITDA
6.32
2.76%
Dividend Yield
3.17%
ABBV: 5Ties: 1CMS: 2
ABBVCMS

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

CMS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
CMS
$2.73
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$1.09B
Δ Market Cap
+$2.98B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
40.7% Overvalued
Price is 40.7% above estimated fair value
Current Price: $250.94
Fair Value: $178.31
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
CMS
547.0% Overvalued
Price is 547.0% above estimated fair value
Current Price: $71.99
Fair Value: $11.13
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

CMS

Requires positive FCF to compute implied growth rate.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
CMS
25/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though margin stability shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
CMS
-2.43
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,146
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
CMS
Insiders 0.5%Institutions 100.0%
No. of Institutional Holders1,136
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
CMS
0
Buys (3M)
1
Buys (12M)
Total value (12M): $153,398
LEOPOLD DIANE
Director
$153,398
@ $76.70 · 2026-02-25
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
0
Sells (12M)
No open market insider sales found.
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
CMS
1
Sells (3M)
7
Sells (12M)
Total value (12M): $2.40M
HOFMEISTER BRANDON J
Officer
$222,930
@ $74.31 · 2026-05-26
MCINTOSH SCOTT B.
Officer
$136,859
@ $78.21 · 2026-03-02
HOFMEISTER BRANDON J
Officer
$312,940
@ $78.23 · 2026-02-27
RUSSELL JOHN G.
Director
$1.13M
@ $75.75 · 2026-02-20
HOFMEISTER BRANDON J
Officer
$289,882
@ $72.47 · 2025-11-03
SNYDER LAUREN Y
Officer
$158,199
@ $71.26 · 2025-09-05
HOFMEISTER BRANDON J
Officer
$147,246
@ $73.62 · 2025-08-08
HOFMEISTER BRANDON J
Officer
$161,790
@ $73.61 · 2025-05-06
HOFMEISTER BRANDON J
Officer
$147,540
@ $73.77 · 2025-03-03
WRIGHT LAURA H
Director
$174,609
@ $69.84 · 2025-02-19
MCINTOSH SCOTT B.
Officer
$467,392
@ $69.76 · 2025-02-13
RUSSELL JOHN G.
Director
$1.89M
@ $65.85 · 2024-12-19
HOFMEISTER BRANDON J
Officer
$134,443
@ $67.22 · 2024-12-13
MCINTOSH SCOTT B.
Officer
$64,116
@ $68.50 · 2024-11-21
HOFMEISTER BRANDON J
Officer
$136,345
@ $68.17 · 2024-11-18
HOFMEISTER BRANDON J
Officer
$137,709
@ $68.85 · 2024-09-04
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(61/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
CMS
FearGreed
😐Neutral(48/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
CMS
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (48)
View ABBV Full AnalysisView CMS Full Analysis

Frequently Asked Questions: ABBV vs CMS

Is AbbVie Inc. or CMS Energy Corporation more undervalued in 2026?

Based on our discounted cash flow model, ABBV trades at a -40.7% margin of safety (intrinsic value $178 vs. price $251), compared to CMS's -547.0% margin of safety (intrinsic $11 vs. $72).

Which stock has a wider economic moat, AbbVie Inc. or CMS Energy Corporation?

ABBV scores 82/100 (Wide moat), while CMS scores 25/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is CMS Energy Corporation in financial distress?

CMS's Altman Z-Score of 0.9 places it in the Distress zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or CMS Energy Corporation?

ABBV earns 27.6% ROIC versus CMS's 4.0%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or CMS Energy Corporation's?

CMS's dividend earns a safety score of 69/100 (Safe), compared to ABBV's 39/100 (Unsafe). CMS has raised its dividend for 3 consecutive years.